Baxion
Screening
Tags
Alerts
Theme
Arcutis Biotherapeutics, Inc.
ARQT
·
NASDAQ
·
$21.11
Share Price as of 11/2
·
$3B
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/05/26
10-Q
Q1 ended 03/31/26
05/06/26
10-K
FY 2025
02/25/26
10-Q
Q3 ended 09/30/25
10/28/25
10-Q
Q2 ended 06/30/25
08/06/25
Disclosures
Filter
8-K
Current report
10/28/26
8-K
Results of Operations; Change in Directors or Officers
08/05/26
8-K
Change in Directors or Officers; Regulation FD Disclosure
07/16/26
8-K
Current report
06/09/26
8-K
Current report
05/06/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
04/21/26
S-3ASR
Automatic shelf registration
02/25/26
S-8
Registration of securities for employees
02/25/26
S-8
Registration of securities for employees
02/25/25
424B5
Prospectus supplement
03/01/24
Proxies
Filter
DEF 14A
Definitive proxy
04/21/26
DEFA14A
Additional proxy materials
04/21/26
DEF 14A
Definitive proxy
04/29/25
DEFA14A
Additional proxy materials
04/29/25
DEF 14A
Definitive proxy
04/26/24
Ownership
Filter
Form 3
Initial insider ownership
10/28/26
Form 4
Insider transaction
10/28/26
144
Proposed sale of securities
10/20/26
Form 4
Insider transaction
10/19/26
144
Proposed sale of securities
10/15/26
Other
Filter
ARS
Annual report to shareholders
04/21/26
UPLOAD
Letter from the SEC
12/02/25
CORRESP
Correspondence with the SEC
10/10/25
UPLOAD
Letter from the SEC
09/15/25
ARS
Annual report to shareholders
04/29/25
Latest Filings
Filter
8-K
Current report
10/28/26
10-Q
Q2 ended 06/30/26
08/05/26
8-K
Results of Operations; Change in Directors or Officers
08/05/26
8-K
Change in Directors or Officers; Regulation FD Disclosure
07/16/26
8-K
Current report
06/09/26
Ownership
Filter
Form 3
Initial insider ownership
10/28/26
Form 4
Insider transaction
10/28/26
144
Proposed sale of securities
10/20/26
Form 4
Insider transaction
10/19/26
144
Proposed sale of securities
10/15/26